Cytek Biosciences, Inc. (CTKB): Total Assets

Annual figures by period end, from SEC filings.

$461.54M
As of 2025-12-31
$446.93M
As of 2026-06-30
-3.9%
3-year compound annual growth
+16.0%
5-year compound annual growth
$519.48M2020-12-31: $219.98M2021-12-31: $463.31M2022-12-31: $519.48M2023-12-31: $494.46M2024-12-31: $499.50M2025-12-31: $461.54M$461.54M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$461.54M-7.6%2026-02-26, Balance as of period end
2024-12-31$499.50M+1.0%2026-02-26, Balance as of period end
2023-12-31$494.46M-4.8%2025-02-28, Balance as of period end
2022-12-31$519.48M+12.1%2024-03-13, Balance as of period end
2021-12-31$463.31M+110.6%2023-03-01, Balance as of period end
2020-12-31$219.98Mn/a2022-03-17, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Cytek Biosciences, Inc. (CTKB)2025-12-31$461.54M-7.6%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$784.08M-37.8%
Quanterix Corp (QTRX)2025-12-31$418.77M+3.0%
Harvard Bioscience Inc (HBIO)2025-12-31$80.07M-36.8%
10x Genomics, Inc. (TXG)2025-12-31$1.04B+13.4%
908 Devices Inc. (MASS)2025-12-31$190.07M+19.2%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$74.85M-23.8%
EyePoint, Inc. (EYPT)2025-12-31$364.00M-13.0%
Bionano Genomics, Inc. (BNGO)2025-12-31$73.58M-4.0%

Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗